Business Description
Biorem Inc
NAICS : 562998
SIC : 4999
ISIN : CA09068G1046
Description
Biorem Inc is an environmental biotechnology company. It is involved in the manufacturing of a comprehensive line of high efficiency air pollution control systems that are used to eliminate odorous and harmful contaminants. The company's products include Biofilters, Biogas Solutions, Multi-Stage Systems, Biotrickling filters, and services such as Media Sampling and Analysis, Biological processes and testing, Media replacements and Spare parts, and other related services. The company derives revenues from the sale of standard products, construction projects for specialized products, and services for repairs and maintenance. The group has a business presence in Canada, the United States, China and others, of which key revenue is derived from the United States.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.95 | |||||
| Equity-to-Asset | 0.41 | |||||
| Debt-to-Equity | 0.38 | |||||
| Debt-to-EBITDA | 0.49 | |||||
| Interest Coverage | 30.1 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 4.85 | |||||
| Beneish M-Score | -2.53 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 33.6 | |||||
| 3-Year EBITDA Growth Rate | 37.1 | |||||
| 3-Year EPS without NRI Growth Rate | 40.4 | |||||
| 3-Year Book Growth Rate | 6.9 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 29.09 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 20.58 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 20.67 | |||||
| 9-Day RSI | 32.69 | |||||
| 14-Day RSI | 37.83 | |||||
| 3-1 Month Momentum % | -17.17 | |||||
| 12-1 Month Momentum % | 60.78 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.91 | |||||
| Quick Ratio | 1.66 | |||||
| Cash Ratio | 0.64 | |||||
| Days Inventory | 22.28 | |||||
| Days Sales Outstanding | 75.17 | |||||
| Days Payable | 59.94 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | 26 | |||||
| Shareholder Yield % | 1.34 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 31.91 | |||||
| Operating Margin % | 17.62 | |||||
| Net Margin % | 12.91 | |||||
| FCF Margin % | 12.82 | |||||
| ROE % | 71.4 | |||||
| ROA % | 23.12 | |||||
| ROIC % | 46.01 | |||||
| 3-Year ROIIC % | 8.21 | |||||
| ROC (Joel Greenblatt) % | 226.27 | |||||
| ROCE % | 68.44 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 8.58 | |||||
| Forward PE Ratio | 11.5 | |||||
| PE Ratio without NRI | 8.52 | |||||
| Shiller PE Ratio | 32.52 | |||||
| Price-to-Owner-Earnings | 9.62 | |||||
| PS Ratio | 1.21 | |||||
| PB Ratio | 4.02 | |||||
| Price-to-Tangible-Book | 3.94 | |||||
| Price-to-Free-Cash-Flow | 8.97 | |||||
| Price-to-Operating-Cash-Flow | 8.49 | |||||
| EV-to-EBIT | 4.99 | |||||
| EV-to-EBITDA | 4.65 | |||||
| EV-to-Revenue | 0.88 | |||||
| EV-to-Forward-Revenue | 0.9 | |||||
| EV-to-FCF | 7.05 | |||||
| Price-to-GF-Value | 1.56 | |||||
| Price-to-Projected-FCF | 1.04 | |||||
| Price-to-Median-PS-Value | 1.94 | |||||
| Price-to-Graham-Number | 1.21 | |||||
| Price-to-Net-Current-Asset-Value | 5.28 | |||||
| Earnings Yield (Greenblatt) % | 20.04 | |||||
| FCF Yield % | 13.19 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Biorem Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil C$) | 40.311 | ||
| EPS (TTM) (C$) | 0.295 | ||
| Beta | 0.6 | ||
| 3-Year Sharpe Ratio | 0.93 | ||
| 3-Year Sortino Ratio | 2 | ||
| Volatility % | 45.32 | ||
| 14-Day RSI | 37.83 | ||
| 14-Day ATR (C$) | 0.160521 | ||
| 20-Day SMA (C$) | 2.68 | ||
| 12-1 Month Momentum % | 60.78 | ||
| 52-Week Range (C$) | 1.37 - 3.45 | ||
| Shares Outstanding (Mil) | 15.8 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Biorem Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Biorem Inc Stock Events
| Event | Date | Price (C$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Biorem Inc Frequently Asked Questions
What is Biorem Inc(TSXV:BRM)'s stock price today?
The current price of TSXV:BRM is C$2.48. The 52 week high of TSXV:BRM is C$3.45 and 52 week low is C$1.37.
When is next earnings date of Biorem Inc(TSXV:BRM)?
The next earnings date of Biorem Inc(TSXV:BRM) is .
Does Biorem Inc(TSXV:BRM) pay dividends? If so, how much?
Biorem Inc(TSXV:BRM) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers